Skip to content
OpenCapital
Get started

Innoviva, Inc. INVA Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Merck & Co. logo
Merck & Co.MRK
$297.4B+31.2%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Insmed logo
InsmedINSM
$35.25B+155%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$1.02B+62.1%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B—
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K—
Free cash flow$34.8M-28.4%

Valuation

See full
Enterprise value$1.4B+9.7%
P/E3.5×—
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%—
Debt / equity0.2×—
Current ratio21.1×+18.7×

Where this comes from

Computed from the period-end share price: $1.73B.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s market capitalization?
Innoviva, Inc. (INVA) reported market capitalization of $1.73B in Q1 2026.
How has Innoviva, Inc.'s market capitalization changed year-over-year?
Innoviva, Inc.'s market capitalization increased by 51.8% year-over-year, from $1.14B to $1.73B.
What is the long-term trend for Innoviva, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Innoviva, Inc.'s market capitalization has grown at a 11.7% compound annual growth rate (CAGR), from $861.01M to $1.49B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.